Defining the factors that contribute to on-target specificity of antisense oligonucleotides

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Lima, Walt F ^a   Vickers, Timothy A ^a   Nichols, Josh ^a   Li, Cheryl ^a   Crooke, Stanley T ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COPPER ZINC SUPEROXIDE DISMUTASE; RNA; RNA BINDING PROTEIN; MESSENGER RNA; RIBONUCLEASE H; RIBONUCLEASE HI; SUPEROXIDE DISMUTASE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL FREE SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; RNA BINDING; RNA SPLICING; BASE PAIRING; CELL LINE; CHEMISTRY; GENE EXPRESSION; GENE ORDER; GENETICS; METABOLISM;

BASE PAIRING; BINDING SITES; CELL LINE; CELL-FREE SYSTEM; GENE EXPRESSION; GENE ORDER; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; RIBONUCLEASE H; RNA SPLICING; RNA, MESSENGER; RNA-BINDING PROTEINS; SUPEROXIDE DISMUTASE; TRANSCRIPTION, GENETIC;

EID: 84905055558     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101752     Document Type: Article

References (52)

1. th ED. Vol. 5, pp115-166, John Wiley and Sons, Inc., New York.
2. Crooke ST (1999) Molecular mechanisms of antisense drugs. Biochem Biophys Acta, 1489 (1), 31-43.
3. Crooke ST (2001) In Antisense Technology: Principles, Strategies, and Applications (Crooke, S. T., ed) pp. 1-28, Marcel Dekker, Inc., New York.
4. Wu H, Lima WF, Zhang H, Fan A, Sun H, et al. (2004) Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs. J Biol Chem, 279 (17), 17181-17189. (Pubitemid 38560475)
5. Itaya M, Kondo K (1991) Molecular cloning of a ribonuclease H (RNase HI) gene from an extreme thermophile Thermus thermophilus HB8: a thermostable RNase H can functionally replace the Escherichia coli enzyme in vivo. Nucleic Acids Res, 19 (16), 4443-4449. (Pubitemid 21912822)
6. Itaya M, McKelvin D, Chatterjee SK, Crouch RJ (1991) Selective cloning of genes encoding RNase H from Salmonella typhimurium, Saccharomyces cerevisiae and Escherichia coli rnh mutant. Mol Gen Genet, 227 (3), 438-445.
7. Kanaya S, Itaya M (1992) Expression, purification, and characterization of a recombinant ribonuclease H from Thermus thermophilus HB8. J Biol Chem, 267 (14), 10184-10192.
8. Busen W (1980) Purification, subunit structure, and serological analysis of calf thymus ribonuclease H1. J Biol Chem, 255 (19), 9434-9443.
9. Rong YW, Carl PL (1990) On the molecular weight and subunit composition of calf thymus ribonuclease H1. Biochemistry, 29 (2), 383-389. (Pubitemid 20037644)
10. Eder PS, Walder JA (1993) Substrate specificity of human RNase H1 and its role in excision repair of ribose residues misincorporated in DNA. Biochimie, 75 (1), 6472-6479.
11. Vickers TA, Koo S, Bennett CF, Crooke ST, Dean NM, et al. (2003) Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J Biol Chem, 278 (9), 7108-7118. (Pubitemid 36800708)
12. Bennett CF, Swayze EE (2010) RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform. Annual Review of Pharmacology and Toxicology, 50 (1), 259-293.
13. nd ED. pp 143-182, CBC press, New York.
14. Monia BP, Johnston JF, Ecker DJ, Zounes MA, Lima WF, et al. (1992) Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J Biol Chem, 267 (28), 19954-19962.
15. Monia BP, Lesnik EA, Gonzalez C, Lima WF, McGee D, et al (1993) Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J Biol Chem, 268 (19), 14514-14522. (Pubitemid 23195583)
16. Baker BF, Lot SS, Condon TP, Cheng-Flournoy S, Lesnik EA, et al. (1997) 2′-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J Biol Chem, 272, 11994-12000. (Pubitemid 27202775)
17. Wagner RW, Matteucci MD, Lewis JG, Gutierrez AJ, Moulds C, et al. (1993) Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science, 260 (5113), 1510-1513. (Pubitemid 23273266)
18. Monia BP, Sasmor H, Johnston JF, Freier SM, Lesnik EA, et al. (1996) Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo. Proc Natl Acad Sci U S A, 93 (26), 15481-15484. (Pubitemid 27009624)
19. Freier SM, Altmann KH (1997) The ups and downs of nucleic acid duplex Structure-stability studies on chemically-modified DNA:RNA duplexes. Nucleic Acids Res, 25 (22), 4429-4443. (Pubitemid 27500751)
20. Lima WF, Monia BP, Ecker DJ, Freier SM (1992) Implication of RNA structure on antisense oligonucleotide hybridization kinetics. Biochemistry, 31 (48), 12055-12061. (Pubitemid 23011348)
21. Mathews DH, Burkard SM, Freier SM, Wyatt JR, Turner DH (1999) Predicting oligonucleotide affinity to nucleic acid targets. RNA, 5 (11), 1458-1469. (Pubitemid 29530490)
22. nd ED. pp 118-138, CBC press, New York.
23. Baughan TD, Dickson A, Osman EY, Lorson CL (2009) Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy. Hum Mol Genet, 18 (9), 1600-1611.
24. Cartegni L, Krainer AR (2003) Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat Struct Mol Biol, 10 (2), 120-125. (Pubitemid 36177092)
25. Skordis LA, Dunckley MG, Yue B, Eperon IC, Muntoni F (2003) Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts. Proc Natl Acad Sci USA, 100 (7), 4114-4119. (Pubitemid 36418166)
26. Villemaire J, Dion I, Elela SA, Chabot B (2003) Reprogramming alternative premessenger RNA splicing through the use of protein-binding antisense oligonucleotides. J Biol Chem, 278 (50), 50031-50039. (Pubitemid 37548839)
27. Goraczniak R, Behlke MA, Gunderson SI (2009) Gene silencing by synthetic U1 adaptors. Nat Biotechnol, 27 (3), 257-263.
28. Rigo F, Hua Y, Chun SJ, Prakash TP, Krainer AR, et al. (2012) Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing. Nat Chem Biol, 8 (6), 555-561.
29. Lee J, Lee H-J, Shin M-K, Ryu W-S (2004) Versatile PCR-mediated insertion or deletion mutagenesis. Biotechniques, 36 (3), 398-400. (Pubitemid 38299052)
30. Mckay R, Miraglia L, Cummins L, Owens S, Sasmor HM, et al. (1999) Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-α expression. J Biol Chem, 274 (3), 1715-1722.
31. nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
32. Vickers TA, Lima WF, Nichols JG, Crooke ST (2007) Reduced levels of Ago2 expression result in increased siRNA competition in mammalian cells. Nucleic Acids Res, 35 (19), 6598-6610. (Pubitemid 350111625)
33. Lima WF, Wu H, Nichols JG, Manalili SM, Drader JJ, et al. (2003) Human RNase H1 activity is regulated by a unique redox switch formed between adjacent cysteines. J Biol Chem, 278 (17), 14906-14912. (Pubitemid 36799819)
34. Vickers TA, Zhang H, Graham MJ, Lemonidis KM, Zhao C, et al. (2006) Modification of MyD88 mRNA Splicing and Inhibition of IL-1beta Signaling in Cell Culture and in Mice with a 2′-O-Methoxyethyl-Modified Oligonucleotide. J Immunology, 176 (6), 3652-3661. (Pubitemid 43364012)
35. Winer J, Kwang C, Jung S, Shackel I, Williams PM (1999) Development and Validation of Real-Time Quantitative Reverse Transcriptase±Polymerase Chain Reaction for Monitoring Gene Expression in Cardiac Myocytes in Vitro. Anal Biochem, 270 (1), 41-49. (Pubitemid 29230718)
36. Hashimoto JG, Beadles-Bohling AS, Wiren KM (2004) Comparison of RiboGreen and 18S rRNA quantitation for normalizing real-time RT-PCR expression analysis. Biotechniques, 36 (1), 58-60.
37. Kataoka N, Yong J, Kim VN, Velazquez F, Perkinson RA, et al. (2000) Pre-mRNA splicing imprints mRNA in the nucleus with a novel RNA-binding protein that persists in the cytoplasm. Mol Cell, 6 (3), 673-682.
38. Le Hir H, Gatfield D, Izaurralde E, Moore MJ (2001) The exon-exon junction complex provides a binding platform for factors involved in mRNA export and NMD. EMBO J, 20 (17), 4987-4997. (Pubitemid 32848650)
39. Le Hir H, Izaurralde E, Maquat LE, Moore MJ (2000) The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions. EMBO J, 19 (24), 6860-6869. (Pubitemid 32011679)
40. Jamison SF, Crow A, Garcia-Blanco MA (1992) The spliceosome assembly pathway in mammalian extracts. Mol Cell Biol, 12 (10), 4279-4287.
41. Seraphin B, Rosbash M (1989) Identification of functional U1 snRNA premessenger RNA complexes committed to spliceosome assembly and splicing. Cell, 59 (2), 349-358. (Pubitemid 19264379)
42. Ghisolfi-Nieto L, Joseph G, Puvion-Dutilleul F, Amalric F, Bouvet P (1996) Nucleolin is a Sequence-specific RNA-binding Protein: Characterization of Targets on Pre-ribosomal RNA. J Mol Biol, 260 (1), 134-153.
43. Abdelhaleem M, Maltais L, Wain H (2003) The human DDX and DHX gene families of putative RNA helicases. Genomics, 81 (6), 618-622. (Pubitemid 36627504)
44. Chou MY, Rooke N, Turck CW, Black DL (1999) hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells. Mol Cell Biol, 19 (1), 69-77. (Pubitemid 29018410)
45. Yang X, Bani MR, Lu SJ, Rowan S, Ben-David Y et al. (1994) The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5′ splice site selection in vivo. Proc Natl Acad Sci U S A, 91, 6924-6928.
46. Caputi M, Zahler AM (2001) Determination of the RNA Binding Specificity of the Heterogeneous Nuclear Ribonucleoprotein (hnRNP) H/H′/F/2H9 Family. J Biol Chem, 276 (47), 43850-43859.
47. Reichert VL, Le Hir H, Jurica MS, Moore MJ (2002) 50 exon interactions within the spliceosome establish a framework for exon junction complex structure and assembly. Genes Dev, 16, 2778-2791. (Pubitemid 35253146)
48. Shibuya T, Tange TO, Sonenberg N, Moore MJ (2004) eIF4AIII binds spliced mRNA in the exon junction complex and is essential for nonsense mediated decay. Nat Struct Mol Biol, 11 (4), 346-351. (Pubitemid 38436799)
49. Yao F, Svensjo T, Winkler T, Lu M, Eriksson C, Eriksson E (1998) Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum Gene Ther, 9, 1939-1950. (Pubitemid 28439099)
50. Seth PP, Jazayeri A, Yu J, Allerson CR, Bhat B, et al. (2012) Structure Activity Relationships of alpha-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals. Mol Ther Nucleic Acids, 1, e47.
51. Lima WF, Brown-Driver V, Fox M, Hanecak R, Bruice TW (1997) Combinatorial screening and rational for hybridization to folded Hepatitis C virus RNA of oligonucleotides with biological antisense activity. J Biol Chem, 272 (1), 626-638. (Pubitemid 27021203)
52. Arhin GK, Boots M, Bagga PS, Milcarek C, Wilusz J (2002) Downstream sequence elements with different affinities for the hnRNP H/H′ protein influence the processing efficiency of mammalian polyadenylation signals. Nucleic Acids Res, 30 (8), 1842-1850. (Pubitemid 34679763)